In milestone trial, experimental drug delays type 1 diabetes

Marking the culmination of a 33-year odyssey, scientists today report a milestone in type 1 diabetes: the first time the disease has been markedly delayed in young people at high risk. Presenting at the American Diabetes Association meeting in San Francisco and publishing simultaneously in the New England Journal of Medicine, researchers found that 2 […]